ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
630 |
278K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
630
|
278K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
8 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
15 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
19K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
19K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
19K |
5 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
19K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Wilba32
|
41 |
19K |
9 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
41
|
19K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
10 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
General
|
|
Re:
Ads that cover whole screen and don’t go away
|
|
Wilba32
|
20 |
3.5K |
0 |
07/04/24 |
07/04/24 |
General
|
20
|
3.5K
|
0
|
|
General
|
|
Re:
Ads that cover whole screen and don’t go away
|
|
Wilba32
|
20 |
3.5K |
1 |
07/04/24 |
07/04/24 |
General
|
20
|
3.5K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
10 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Class Action
|
|
Wilba32
|
218 |
68K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
218
|
68K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Wilba32
|
52 |
24K |
24 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
24K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Morningstar, Fair value for MSB Shareprice: $2.23/s
|
|
Wilba32
|
11 |
5.4K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
11
|
5.4K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
10 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Morningstar, Fair value for MSB Shareprice: $2.23/s
|
|
Wilba32
|
11 |
5.4K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
11
|
5.4K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
11 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Upcoming Newsflow & Re-rate Estimations
|
|
Wilba32
|
52 |
24K |
5 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
52
|
24K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
13 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Wilba32
|
116 |
44K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
44K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Wilba32
|
116 |
44K |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
44K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Wilba32
|
116 |
44K |
11 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
44K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Wilba32
|
116 |
44K |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
44K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Wilba32
|
272 |
104K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
272
|
104K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Wilba32
|
272 |
104K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
272
|
104K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Wilba32
|
877 |
371K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
877
|
371K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.0K
|
426K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
88 |
40K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
40K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.0K
|
426K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
88 |
40K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
40K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
630 |
278K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
630
|
278K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
630 |
278K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
630
|
278K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.5K |
2.7M |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
4 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
7 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.8M |
26 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Wilba32
|
31 |
11K |
49 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
31
|
11K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
11 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.0K
|
426K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
630 |
278K |
21 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
630
|
278K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Wilba32
|
1.4K |
369K |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.4K
|
369K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
6 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
1.0K
|
426K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
10 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
1.0K
|
426K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
426K |
8 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
1.0K
|
426K
|
8
|
|